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The abstracts below represent the winners in the Residents and Medical Students categories
at the 2014 Missouri ACP Chapter meeting.
Winner, Research Poster for Missouri ACP 2014.
Evaluation of the reporting process of the tests pending at discharge in an academic
hospital.
Saiprasad Narsingam, M.D., Sood Kisra, M.D., Samrat Patel, M.D., Mihir Brahmbhatt, Asha
George, Vritti Gupta, John Foxworth, Pharm.D.
Internal Medicine Department, School of Medicine, University of Missouri-Kansas City, Kansas
City, MO 64108
Introduction: A patient’s hospital stay involves multiple diagnostic tests done for various
indications. Not uncommonly, the final results of diagnostic tests including lab tests, radiology,
pathology and microbiology come back after a patient is discharged. A number of times, these
results might not be clinically significant but sometimes they are. These results are to be
discussed with the patients, and action taken, in a timely manner. Not uncommonly, these
results go unreported and are missed. We aim to study how the reporting process is working
in our hospital focusing on medical inpatients, and to find solutions to any problems that may
exist.
Methods: We performed a retrospective chart review of all medical in-patients at Truman
Medical Center-Hospital Hill (TMC-HH) who were discharged in the month of July 2014 and
had tests pending at the time of discharge (TPADs). Appropriate descriptive statistics were
used for nominal and ordinal data.
Results: A total of 229 instances of TPADs were identified. Fifty percent belonged to
chemistry, 34% belonged to pathology, 12% belonged to radiology and 4% to microbiology.
Twenty eight percent of TPADs were clinically actionable. Discharge summaries included
actionable TPADs in 82% of the cases. Appropriate action was taken in 92% of the actionable
TPADs. Action was taken in 52% of the cases within one week and 82% of the cases within
one month after results arrived.
Conclusion: The discharge process is a critical step in a patient’s hospital course. Our data
gives us insights into our discharge process and the reporting of TPADs. Most of the TPADs
were acted upon with the patients and in a timely manner. The majority of the discharge
summaries documented actionable TPADs. There is still room for improvement.
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Nutritional Knowledge in Internal Medicine Residents.
Peter Yen, MD, Dominic Reeds, MD.
Washington University School of Medicine/Barnes-Jewish Hospital, Department of Medicine,
St. Louis, MO 63110
Introduction: Malnutrition affects approximately 30% of inpatients world-wide and is strongly
associated with adverse outcomes, but is often poorly addressed by house-staff. The purpose
of our study was to identify educational deficiencies in the knowledge base of internal
medicine resident physicians.
Methods: For 2.5 months, nutrition competency was assessed by comparing inpatient diet
orders made by medicine residents with dietician recommendations. Information collected
included diet orders, patient age and gender, and resident year of training. Diet orders made
by residents were classified as “concordant” or “discordant” depending on agreement with
dietician recommendations. Malnutrition was defined using ASPEN criteria. The students’ t-
test, chi-square test, and z-tests of proportions were used where appropriate.
Results: Of 1,419 patients reviewed, 17% were evaluated by dietitians for diet alone, and 8%
for malnutrition. Of patients identified as malnourished, residents made the diagnosis of
malnutrition in only 40% (45/111). Futhermore, only 17% of house-staff orders were
concordant with dietitian recommendations (19/111). Concordance of diet orders was related
to resident ability to diagnose malnutrition (p=0.08). Discordant orders were more common in
resident-identified patients than resident-missed patients (p=0.045). Overall, results did not
differ with respect to age and gender.
Conclusion: Resident physicians perform poorly in diagnosing malnourished patients, a
population at need for early appropriate intervention. Similarly, residents were poor at
prescribing appropriate diets in the vast majority of patients. Graduate programs should
improve training in identifying malnourished patients and promote a better understanding of
factors involved in selecting an appropriate diet.
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host
disease: Impact on six month freedom from treatment failure.
Li Zhou, Emma Das-Gupta, Hildegard Greinix, Ryan Jacobs, Bipin N. Savani, Brian G.
Engelhardt, Adetola Kassim, Nina Worel, Robert Knobler, Nigel Russell, Madan Jagasia.
Extracorporeal photopheresis (ECP) is a promising treatment for corticosteroid-refractory or
dependent acute graft-vs-host disease (GVHD). However, traditional clinical endpoints used in
studies to evaluate treatments of this complication incompletely capture a patient’s clinical
response. Six-month freedom from treatment failure (FFTF) has been proposed as a novel
clinical trial endpoint and is defined by the absence of death, malignancy relapse/progression,
or addition of next line of systemic immunosuppressive therapy within 6 months of intervention
and prior to diagnosis of chronic GVHD. In this study, we analyzed 128 patients enrolled from 3
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centers treated with ECP as second-line therapy for acute GVHD. Our study demonstrated
that 6 month FFSF correlates strongly with overall survival at 1 year (78.9%), 2 years (70.8%),
and 3 years (69.5%). Furthermore, the incidence of 6 month FFTF was 77.3% with a 2-year
survival of 56%. Grade of aGVHD (grade 2 vs. 3-4) at onset of second-line therapy was an
important determinant of outcome, as measured by survival (HR 2.78, P<0.001), non-relapse
mortality (HR 2.78, P=0.001) and 6 month FFTF (HR 3.05, P<0.001). Our study supports the
use of 6 month FFTF as a clinical trial endpoint for evaluating second line treatments in steroid
refractory/dependent acute GVHD, and demonstrates the efficacy of ECP in this patient
population.
Winner: 2014 ACP-Missouri Chapter Medical Student Competition
Targeted Delivery of Phosphodiesterase Inhibitors to Erythrocytes: Implications for the
Treatment of Vascular Disease in Type 2 Diabetes.
Weston R. Gordon, Elizabeth A. Bowles, and Randy S. Sprague, MD.
Department of Pharmacological and Physiological Science, Saint Louis University, St. Louis,
MO
In skeletal muscle, when erythrocytes (RBCs) are exposed to low O , they release both O  and
the potent vasodilator, ATP, permitting these cells to alter distribution of perfusion to meet
tissue O  need.  However, in humans with Type 2 Diabetes (DM2), ATP release from RBCs in
response to low O  is lost.  This defect could contribute to the associated peripheral vascular
disease (PVD).  A signaling pathway for low O -induced ATP release from RBCs that requires
increases in cAMP that are regulated by Phosphodiesterase 3 (PDE3) has been defined. 
Although the use of the PDE3 inhibitor cilostazol (CILO) in DM2 is attractive, side effects limit
its use.  In addition PDE3 can also be inhibited by cGMP, a cyclic nucleotide that is regulated
by PDE5.  The aims of this study were to 1) construct liposomes containing the PDE3 inhibitor,
CILO, and determine if the directed delivery to DM2 RBCs restores low O -induced ATP
release and 2) determine if the PDE5 inhibitors, zaprinast (ZAP) or tadalafil (TAD), also rescue
low O -induced ATP release from DM2 RBCs.  RBCs from healthy humans and humans with
DM2 were exposed to both normal and reduced pO  using a thin-film tonometer in the
presence of either empty dimyristoylphosphatidylcholine liposomes or liposomes containing
CILO, ZAP, or its vehicle dimethylformamide (DMF).  In healthy human RBCs, ATP release
increased from 13.6±2.3 to 25.2±4.6 with exposure to low O  (P<0.01).  In contrast, when
RBCs of humans with DM2 were incubated with empty liposomes ATP levels did not increase
(15.4±1.4 to 14.7 ± 1.1).  The defect in ATP release was rescued by incubation with liposomes
containing the PDE3 inhibitor, CILO, with ATP increasing from 14.8±1.2 to 23.1±3.8 (P<0.01). 
Similarly, incubation of DM2 RBCs in the absence of liposomes with the PDE5 inhibitors, ZAP
or TAD, also rescued low O -induced ATP release with increases of 9.2±0.9 to 18.7±1.7
(P<0.01) and 14.6±5.0 to 21.1±4.8 (P<0.05), respectively.  In summary, both directed delivery
of a PDE3 inhibitor to RBCs by liposomes and the administration of PDE5 inhibitors alone
rescue low O -induced ATP release from DM2 RBCs.  These results provide new support for
the hypothesis that PDE5 is a component of a signaling pathway for low O -induced ATP
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release from RBCs along with PDE3.  Restoration of this function permits DM2 RBCs to
participate in the regulation of perfusion to meet tissue O need and suggests new approaches
to the treatment and/or prevention of peripheral vascular disease in patients with DM2.
Developing a model for FGF and Notch Signaling Hierarchy in Sensory Neurogenesis
reveals potential pathway for malignancy.
Jacob Voelkel , Jason Adams , Rhonda Lassiter , Michael Stark , Agostino Molteni
1University of Missouri- Kansas City School of Medicine, Kansas City, MO, Physiology and
Developmental Biology, Brigham Young University, Provo, UT
Introduction:  The ophthalmic trigeminal (opV) placode exclusively gives rise to sensory
neurons, making it a good model to study the molecular regulation of sensory neurogenesis. A
number of signaling pathways including Wnt, PDGF, FGF, and Notch have been shown to be
involved in the process of opV placode cell development. However, the regulatory relationship
between these signaling pathways is still unknown, and has been difficult to study
experimentally. Using a novel multifactorial approach in chick embryos that allows for inhibition
of FGF throughout the tissue or in individual cells, with simultaneous inactivation of Notch
signaling, we investigated the potential interaction between the FGF and Notch signaling
pathways in trigeminal sensory neurogenesis.
Methods: To determine if FGF activation acts to modulate Notch signaling in the sensory
neurogenesis pathway, FGF signaling was first inhibited globally with a FGF chemical
antagonist while simultaneously inactivating Notch signaling. FGF signaling was then inhibited
in individual cells via electroporation with a secreted-FGF receptor while concurrently inhibiting
Notch signaling in order to define the interaction between the signaling pathways cell-
autonomously. FGFR4 expression was also analyzed by in situ hybridization after Notch
inhibition to determine if Notch downregulation allows for broadened FGFR4 expression. 
Finally, the role of FGF and Notch signaling on basement membrane integrity was examined
by inhibiting both pathways individually or collectively and staining for laminin.
Results: FGF pathway inhibition resulted in few cells delaminating from the opV placode and a
statistically significant decrease in the number of cells contributing to ganglion formation.
Conversely, Notch pathway inhibition resulted in a robust expansion of these cells.
Simultaneous FGF and Notch pathway inhibition also resulted in a reduction of cells
delaminating from the opV placode and contributing to the ganglion producing a similar
phenotype to embryos in which the FGF pathway alone was inhibited. Further, Notch inhibition
did not lead to broad enhancement of FGFR4 expression, but instead resulted in a highly
fragmented basal lamina, which was reversed when blocking FGF signaling.
Conclusions and Discussion: Cumulatively, these results do not support a model of
Notch/FGF interdependence, but rather a relationship where FGF and Notch act in parallel to
promote sensory neurogenesis. These conclusions suggest a model where FGF activation
with parallel Notch downregulation lead to basement membrane fragmentation and
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subsequent differentiation of opV placode cells. This proposed model of basement membrane
regulation by FGF and Notch will be a focus of ongoing research and may provide significant
insight as to how some cancer cells become malignant in various cancer cells lines.
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